Dannex Ayrton Starwin (XGHA:DASPHARMA) EBITDA per Share: GHS (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:DASPHARMA Dannex Ayrton Starwin PLC XGHA:DASPHARMA
3 GF Score
Price GHS0.44
! 1 Warning Sign
View Full Analysis

What is Dannex Ayrton Starwin EBITDA per Share?

Dannex Ayrton Starwin XGHA:DASPHARMA 3 EBITDA per Share is GHS as of . 20. GuruFocus rates XGHA:DASPHARMA with a GF Score™ of 3/100. The stock has 1 warning sign investors should review. Among 813 Drug Manufacturers companies, Dannex Ayrton Starwin ranks worse than 123001.11% on this metric.

Dannex Ayrton Starwin's EBITDA per Share for the six months ended in . 20 was GHS0.00. Dannex Ayrton Starwin does not have enough years/quarters to calculate its EBITDA per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Dannex Ayrton Starwin's EBITDA per Share or its related term are showing as below:

XGHA:DASPHARMA's 3-Year EBITDA Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.8
* Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.

Dannex Ayrton Starwin's EBITDA for the six months ended in . 20 was GHS0.00 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.


Dannex Ayrton Starwin  (XGHA:DASPHARMA) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Dannex Ayrton Starwin EBITDA per Share Related Terms


Dannex Ayrton Starwin EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Dannex Ayrton Starwin's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dannex Ayrton Starwin EBITDA per Share Chart

Dannex Ayrton Starwin Annual Data
Trend
EBITDA per Share

Dannex Ayrton Starwin Semi-Annual Data
EBITDA per Share
XGHA:DASPHARMA
3GF Score
Dannex Ayrton Starwin PLC XGHA:DASPHARMA
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dannex Ayrton Starwin EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Dannex Ayrton Starwin's EBITDA per Share for the fiscal year that ended in . 20 is calculated as

EBITDA per Share(A: . 20 )
=EBITDA/Shares Outstanding (Diluted Average)
=/0
=N/A

Dannex Ayrton Starwin's EBITDA per Share for the quarter that ended in . 20 is calculated as

EBITDA per Share(Q: . 20 )
=EBITDA/Shares Outstanding (Diluted Average)
=/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of GHS mean?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a EBITDA per Share of GHS as of . 20. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Dannex Ayrton Starwin and its competitors. According to the industry distribution chart, Dannex Ayrton Starwin ranks #999999 out of 813 companies in the Drug Manufacturers industry.
Is Dannex Ayrton Starwin's EBITDA per Share too high?
Dannex Ayrton Starwin's current EBITDA per Share is GHS. Based on the distribution chart, Dannex Ayrton Starwin ranks #999999 out of 813 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dannex Ayrton Starwin has a GF Score™ of 3/100, reflecting its overall financial health beyond just this single metric.
How does Dannex Ayrton Starwin's EBITDA per Share compare to ?
According to the Drug Manufacturers industry distribution chart, Dannex Ayrton Starwin ranks #999999 out of 813 companies for EBITDA per Share. This places Dannex Ayrton Starwin in the lower half of its industry. The industry median EBITDA per Share is 8.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Drug Manufacturers company?
The median EBITDA per Share among Drug Manufacturers companies is 8.80, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Dannex Ayrton Starwin and its competitors. For the Drug Manufacturers industry, the median EBITDA per Share is 8.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dannex Ayrton Starwin's current EBITDA per Share is GHS. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dannex Ayrton Starwin stock overvalued right now?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a current EBITDA per Share of GHS. The current EBITDA per Share is GHS. Dannex Ayrton Starwin's overall GF Score™ is 3/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Dannex Ayrton Starwin (XGHA:DASPHARMA), the current EBITDA per Share is GHS as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dannex Ayrton Starwin Business Description

Comparable Companies
Address No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.
3GF Score

Get the complete analysis for XGHA:DASPHARMA

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.44
Price